She looked at options like uterine myomectomy and uterine fibroid embolization, but she wanted kids one day. She feared the potential impact on her future fertility. She searched for an effective medication to treat her fibroids and reduce her heavy menstrual bleeding. She wanted to get her life back. 

For many years, women with fibroids have sought out menstrual cycle control options beyond oral contraceptives, Depo-Provera injections, and Progesterone IUDs. In May 2020, the U.S. Food and Drug Administration approved Oriahnn™ for the management of heavy menstrual bleeding associated with uterine fibroids in premenopausal women.

What is Oriahnn™?

Oriahnn™ is the only FDA-approved oral medication designed to improve and lighten heavy periods caused by uterine fibroids. Fibroids, also called leiomyomas, are benign uterine tumors that grow in the uterus. Up to 80% of women will develop one or more uterine fibroids during their lifetime. 

Oriahnn™ is a combination product containing elagolix, estradiol, and a type of progesterone called norethindrone acetate. Elagolix is a gonadotropin-releasing hormone antagonist. This term means it suppresses the ovarian sex hormones estrogen and progesterone, both of which stimulate fibroid growth.

The addition of estradiol and norethindrone acetate adds back some of the female hormones to prevent side effects and help thin out the endometrial lining. 

Oriahnn™ is approved for use in premenopausal women to reduce the amount of bleeding caused by uterine fibroids.

Why would a woman want to try Oriahnn™?

Many women suffering from the effects of fibroids seek a non-surgical treatment to control heavy periods. Medial options allow her to reduce her symptoms without impacting her future fertility. An effective medication will enable her to keep her options open.

Older medications, such as Depo-Lupron (leuprolide acetate), are administered as an injection. This type of medication is costly, poorly covered by insurance companies, and often triggers menopausal symptoms such as hot flashes. 

Oriahnn™ comes packaged as a daily oral medication giving women the options to avoid surgery, procedure, or a birth control method. This pill is clinically proven to reduce heavy menstrual bleeding due to uterine fibroids within one month of taking it. 

Oriahnn™ is not birth control. Patients using this medication who do not want to get pregnant may want to consider a nonhormonal contraceptive option such as condoms, Phexxy, spermicide, copper IUDs, or a diaphragm. 

Does Oriahnn™ work? 

Oriahnn™ was studied in two 6-month clinical trials used for FDA approval. These studies included 591 premenopausal women aged 26–53 with heavy periods due to sonographically-confirmed uterine fibroids.

The participants measured menstrual blood loss (MBL) for two cycles before starting Oriahnn™ or a placebo. Only those with greater than 80 ml of MBL qualified for the study.

In the first study, 68.5% of patients who received Oriahnn showed a reduction in menstrual bleeding compared to 8.7% of patients who received a placebo. 

In the second study, 76.5% of patients who received Oriahnn showed an improvement in blood loss compared to 10.5% of patients who received a placebo.

Oriahnn™ was proven to lighten heavy periods in 70% of women with a 50% reduction in menstrual blood loss. During the 6-month clinical trials, only three women required surgery for their uterine fibroids.

What side effects for Oriahnn™?  

During the clinical trials, about 10% of patients stopped treatment because of any side effects. Of note,7% of women taking the placebo also stopped treatment due to side effects.

The most common reported side effects were hot flashes, headache, fatigue, and irregular uterine bleeding.

All products containing estrogen and progestin combinations increase the risk of thrombotic or thromboembolic disorders, including pulmonary embolism, deep vein thrombosis, stroke, and myocardial infarction. A doctor must evaluate a patient’s medical history to determine if these medications are an appropriate option. 

Oriahnn™ may increase the risk of bone loss so the FDA approval recommends limited its use to 24 months. 

A new medical option for fibroids

Gynecologists now have a new option to help women with fibroids. Women with fibroids who want to avoid surgery or birth control may want to consider Oriahnn™. 

This novel medication, back up by clinical evidence, gives women more choices to reduce menstrual bleeding caused by fibroids. 

The post Oriahnn; A Drug to Stop Heavy Periods for Women With Fibroids appeared first on Medika Life.

Uterine fibroids are benign noncancerous tumors affecting women. Fibroids, also called leiomyomas, are made of muscle cells forming into balls and bumps that grow in the uterus. Up to 80% of women will develop one or more uterine fibroid during their lifetime.¹ 

Many women are unaware they have fibroids. Doctors accidentally discover fibroids during a routine pelvic or pregnancy ultrasound.

Uterine fibroids behave in strange ways. They may grow slowly or quickly, or they may simply stay the same size throughout a woman’s life. Some women will develop more fibroids while other women will not. 

Why do we get uterine fibroids?

We do not know exactly why some women get fibroids, and others do not. Genetics and family history play a role. Having a family member with fibroid increases the risk. Fibroids are most common in African-American women affecting up to 50%. Two female hormones, Estrogen and Progesterone, affect fibroids. Fibroids tend to shrink when the production of these hormones stops after menopause. 

What are the symptoms of uterine fibroids?

Not all women will have symptoms. The size and location of the fibroids in the uterus impact the potential for life-disrupting symptoms as fibroids increase blood flow to the uterus. Fibroids can also impact fertility and the risk of miscarriage. Most fibroids do not cause problems in pregnancy but do increase the risk of preterm labor and fetal growth concerns. 

Size matters with fibroids. Large ones can lead to what we call bulk symptoms. These include:

1. Painful intercourse
2. Pressure or abdominal fullness
3. Increased abdominal size 
4. Frequent urination
5. Constipation
6. Low back pain

The location of the fibroid inside of the uterus plays a role as well. Fibroids increase blood flow to the uterus. These symptoms include:

1. Heavy periods (menorrhagia)
2. Painful periods and cramping (dysmenorrhea)
3. Bleeding after sex (postcoital bleeding)

Types of fibroids

1. Intramural These fibroids are located within the muscular walls of the uterus and typically can cause heavy bleeding, painful intercourse, or pressure symptoms.
2. Submucosal These dangle inside the uterine cavity, typically cause heavy bleeding, irregular bleeding, or bleeding after intercourse. 
3. Subserosal This type of fibroid grows on the outer wall of the uterus. Heavy periods, pelvic pain and bulk or pressure symptoms are common

How are fibroid’s diagnosed?

1. Pelvic exam: A healthcare provider can often diagnose uterine fibroids by feeling the size and shape of the uterus during a pelvic exam. Typically, a confirmation test will then be ordered
2. Ultrasound: Alos called a sonogram, this is a low-cost tool using sound waves to generate an image of the uterus to find, locate and measure the fibroids
3. Magnetic resonance imaging (MRI): MRI is the most accurate imaging tool to identify the size, number, and location of uterine fibroids. An MRI can often help distinguish between benign fibroids and a rare malignant tumor called a leiomyosarcoma.
4. Computerized tomography: CT scan is an alternative to MRI and ultrasound for the analysis of fibroids. 
5. Hysteroscopy: A simple procedure where a doctor uses a small camera to evaluate the inside of the uterine cavity. 
6. Saline infused sonogram: Also called a sonohysterogram, is a special type of ultrasound. A doctor fills the uterus with a small amount of fluid to separate the top of the uterus from the bottom. This technique allows better visualization of the inside of the uterus. 

How are fibroids treated?

1. Hysterectomy: The removal of the uterus. Approximately 40% of hysterectomies in the United States are performed because of fibroids.² While a hysterectomy is the most definitive treatment for fibroids, it also is the most invasive. 
2. Myomectomy: A surgical procedure to remove individual fibroids while preserving the uterus. The size and location of the fibroids in the uterus determine the type of myomectomy. Options include an abdominal, laparoscopic, robotic, and hysteroscopic myomectomy. Myomectomies provide highly effective relief for fibroid symptoms. The original fibroids do not grow back, but new fibroid may develop. 
3. Uterine fibroid embolization: A highly effective option for women who wish to preserve their uterus and avoid surgery. An interventional radiologist performs this procedure through an IV without surgery. Occluding agents are placed into the blood vessel supplying each fibroid. This process starves the fibroid of blood, causing it to shrink. 
4. Radiofrequency fibroid ablation: The Acessa procedure is a minimally invasive, outpatient treatment for fibroids of all types and sizes and in all locations within the uterine wall. This laparoscopic surgery is performed through small incisions using a camera, an ultrasound probe, and the Acessa electrode tip. Heat is used to destroy fibroid tissue causing the fibroid to shrink over time.
5. Endometrial ablation: A short, outpatient surgical procedure to treat abnormal uterine bleeding without the need for incisions. The process destroys the endometrial lining, the tissue responsible for menstrual bleeding. This low-risk option has a 95% patient satisfaction rate and requires minimal patient downtime. Endometrial ablation does not treat or shrink fibroid s but is an effective option to control the associated bleeding. 
6. MRI guided Focused ultrasound: This newer treatment treats fibroids through high-intensity ultrasound. Under MRI guidance, focused ultrasound waves pass through the skin to destroy the fibroids. 

Treatment with Medication

1. Gonadotropin-releasing hormone agonists: GnRH medications are often used preoperatively to temporarily reduce the size of fibroids before surgery. GnRH medications can help decrease blood loss, operative time, recovery time, and sometimes allow a minimally invasive type of hysterectomy. 
2. Progesterone IUD: These thin the endometrial lining. They do not directly treat uterine fibroids but effectively reduce menstrual bleeding.
3. Oral contraceptives: OCPS reduce menstrual bleeding. They do not treat fibroids but are often used to reduce symptoms in women who seek temporary relief.
4. Tranexamic acid: Antifibrinolytic therapy is an effective treatment to reduce the bleeding from uterine fibroids and menorrhagia. This treatment does not directly affect the size of uterine fibroids.
5. Pain medication: Nonsteroidal anti-inflammatory drugs reduce pain and blood loss from fibroids.
6. Selective progesterone receptor modulators: SPRMs such as Ulipristal acetate are newer medications that directly affect the Progesterone receptors. Progesterone is required for cellular proliferation and fibroid growth. This medication is currently FDA for endometriosis, but early clinical trials show promise in bleeding control and fibroid shrinkage. 
7. Oriahnn™ is a combination product containing elagolix, estradiol, and a type of progesterone called norethindrone acetate. Elagolix is a gonadotropin-releasing hormone antagonist. This term means it suppresses the ovarian sex hormones estrogen and progesterone, both of which stimulate fibroid growth

1. Wallach EE, Vlahos NF. Uterine myomas: an overview of development, clinical features, and management. Obstet Gynecol. 2004;104(2):393–406.
2. 3. Whiteman MK, Hillis SD, Jamieson DJ, et al. Inpatient hysterectomy surveillance in the United States, 2000–2004. Am J Obstet Gynecol. 2008;198(1):34.e1–34.e7.

The post Understanding Uterine Fibroids (leiomyomas) appeared first on Medika Life.